Guillaume Rigaut,Alexis Guy André Lucien Parisot,Karelle De Luca,Christine Michele Pierrette Andreoni,Lydie Remolue,Marie Garinot,Jean-François Cotte,Patricia Probeck-Quellec,Jean Haensler,Véronique C
申请号：
US15624405
公开号：
US20170360923A1
申请日:
2017.06.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides for novel immunological and vaccine formulations comprising a newly applied non-crosslinked polyacrylic acid polymer adjuvant. The adjuvants may be combined with a wide variety of immunogens to produce vaccines that are safe and effective when administered to a wide range of target animals. The immunogens may include, but are not limited to: inactivated pathogens, attenuated pathogens, subunits, recombinant expression vectors, plasmids or combinations thereof. The animals may include, but are not limited to: humans, murine, canines, felines, equines, porcines, ovines, caprines and bovines.
